Biophytis S.A. (BPTSY)
BPTSY Stock Price Chart
Explore Biophytis S.A. interactive price chart. Choose custom timeframes to analyze BPTSY price movements and trends.
BPTSY Company Profile
Discover essential business fundamentals and corporate details for Biophytis S.A. (BPTSY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
10 Feb 2021
Employees
22.00
Website
https://www.biophytis.comCEO
Stanislas Veillet
Description
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is BIO101, an orally administered small molecule in development to treat neuromuscular diseases, including sarcopenia, Duchenne muscular dystrophy (DMD), and obesity, as well as treatment of severe respiratory failure in patients suffering from COVID-19. It also develops BIO201, an orally administered small molecule for the treatment of retinopathies, including dry age-related macular degeneration, and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.
BPTSY Financial Timeline
Browse a chronological timeline of Biophytis S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Sept 2025
Earnings released on 11 Jul 2025
Earnings released on 29 May 2025
Earnings released on 27 May 2025
Earnings released on 30 Sept 2024
Earnings released on 27 Sept 2024
EPS came in at -$0.83 .
Stock split effective on 23 Apr 2024
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Apr 2024
EPS came in at -$2.44 surpassing the estimated -$12.90 by +81.08%.
Earnings released on 2 Apr 2024
EPS came in at -$0.83 .
Earnings released on 30 Sept 2023
EPS came in at -$2.44 .
Earnings released on 30 Jun 2023
EPS came in at -$4.74 surpassing the estimated -$20.00 by +76.30%.
Earnings released on 31 Mar 2023
EPS came in at -$4.74 .
Stock split effective on 30 Mar 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Dec 2022
EPS came in at -$11.71 surpassing the estimated -$48.00 by +75.61%.
Earnings released on 30 Sept 2022
EPS came in at -$11.71 .
Earnings released on 30 Jun 2022
EPS came in at -$16.78 .
Earnings released on 31 Mar 2022
EPS came in at -$16.78 .
Earnings released on 31 Dec 2021
EPS came in at -$28.47 .
Earnings released on 30 Sept 2021
EPS came in at -$28.47 surpassing the estimated -$40.00 by +28.83%.
Earnings released on 30 Jun 2021
EPS came in at -$23.93 .
Earnings released on 31 Mar 2021
EPS came in at -$23.93 .
Earnings released on 31 Dec 2020
EPS came in at -$28.57 .
Earnings released on 30 Sept 2020
EPS came in at -$28.57 .
BPTSY Stock Performance
Access detailed BPTSY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.